Celgene plans $8 billion senior notes sale for acquisition, general corporate purposes

By Aleesia Forni

Virginia Beach, July 17 – Celgene Corp. plans to sell approximately $5 billion of senior notes to help finance its acquisition of Receptos, Inc., according to an 8-K filing with the Securities and Exchange Commission.

The company also plans to offer $3 billion of senior notes for general corporate purposes.

The company will also use cash on hand to fund the roughly $7.2 billion deal.

The global biopharmaceutical company is based in Summit, N.J.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.